Organogenesis Inc.

3.64
-0.10 (-2.67%)
At close: Jan 28, 2025, 1:53 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income 4.95M 15.53M 94.90M 17.95M -40.45M -64.83M -2.09M -208.70K -24.26M
Depreciation & Amortization 23.45M 18.03M 16.68M 7.47M 9.43M 6.98M 5.63M 7.32M 7.68M
Stock-Based Compensation 9.00M 6.55M 3.86M 1.66M 936.00K 1.07M 919.00K 473.00K 459.00K
Other Working Capital -30.08M -19.16M -3.60M -4.00K 1.39M -10.23M 1.51M 8.47K 3.90M
Other Non-Cash Items 9.59M 16.85M 17.80M 5.78M 6.12M 18.25M -155.75K -303.80M 8.81M
Deferred Income Tax 2.01M 1.98M -31.98M 112.00K 111.00K 186.00K n/a n/a n/a
Change in Working Capital -18.07M -34.08M -39.29M -26.16M -9.67M -22.40M 1.51M -353.54K -2.89M
Operating Cash Flow 30.92M 24.86M 61.98M 6.80M -33.53M -60.74M -586.60K -562.23K -10.19M
Capital Expenditures -24.36M -33.90M -31.22M -21.14M -6.23M -1.86M -2.43M -1.36M -510.00K
Acquisitions n/a n/a n/a -5.82M n/a 1K -11.79M n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a 2.13M -250.00K 1K -658.00K -310.00M 121.00K
Investing Cash Flow -24.36M -33.90M -31.22M -24.83M -6.23M -1.86M -14.87M -310.00M -389.00K
Debt Repayment -5.17M -3.01M -2.01M -15.91M 37.23M 1.07M 100.00K 11.98M n/a
Common Stock Repurchased n/a -648.00K -737.00K n/a -6.76M n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -332.00K 814.00K 978.00K -6.35M -2.08M -11.43M 19.19M -5.20M 10.79M
Financial Cash Flow -5.50M -2.20M -1.04M 42.47M 78.73M 81.64M -327.58K 311.48M 10.79M
Net Cash Flow 1.05M -11.24M 29.72M 24.44M 38.97M 19.05M -914.18K 914.01K 204.00K
Free Cash Flow 6.55M -9.04M 30.76M -14.34M -39.76M -62.60M -3.01M -1.92M -10.70M

Create Price Alert on ORGO

Your price alert will notify you when the stock price is above 3.64.

Add to Watchlist